Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-19T04:39:53.969Z Has data issue: false hasContentIssue false
  • English
  • Français

Factors associated with hospitalisation of patients with schizophrenia in four European countries

Published online by Cambridge University Press:  16 April 2020

P. Gorwood
P. Gorwood*
Affiliation:
CMME, Sainte-Anne Hospital, University Paris Descartes, 100, rue de la Santé, 75674 Paris cedex 14, France Inserm U894, centre de psychiatrie et de neurosciences, Paris, France
*
⁎ Corresponding author. Tel.: +33 0 1 45 65 85 72; fax: +33 0 1 45 65 89 43. E-mail address: [email protected]
Get access

Abstract

Purpose

To analyse factors associated with hospitalisation in patients with schizophrenia from four European countries, and to investigate whether national specificities might have an impact on the profile of inpatients.

Method

A randomly selected sample of psychiatrists (N = 744), from Germany, Greece, Italy and Spain, collected data on the five last patients with schizophrenia they had seen in consultation (N = 3996).

Results

High positive symptoms, lack of insight, not living with the family, frequent past episodes, addiction to illegal drugs, global severity, uncooperativeness and smoking were significantly associated with hospitalisation, with OR between 4.1 and 1.26. Nevertheless, only high positive symptoms from the PANSS and lack of insight were systematically detected in the four countries. Among different results, the weight of “not living with the family” had national specificities, as Germany was the only country where this factor played no role (OR = 0.94).

Conclusion

Although some factors such as positive symptoms are associated with hospitalisation in a very homogenous way throughout different countries, discrepancies were detected between countries, for “living with the family”, “number of past acute relapses” and “uncooperativeness”. Linking these specificities to national healthcare systems might be useful to promote access to care for all patients.

Keywords

Access to careEuropeHealthcareSchizophreniaHospitalization
Type
Original article
Information
European Psychiatry , Volume 26 , Issue 4 , May 2011 , pp. 224 - 230
Copyright
Copyright © Elsevier Masson SAS 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ali, WSchizophrenia and hospitalization. J Coll Physicians Surg Pak 2006; 16: 223–226.Google ScholarPubMed
Angermeyer, MC, Goldstein, JM, Kuehn, LGender differences in schizophrenia: rehospitalization and community survival. Psychol Med 1989; 19: 365–382.CrossRefGoogle ScholarPubMed
Angermeyer, MC, Holzinger, A, Matschinger, HMental health literacy and attitude towards people with mental illness: a trend analysis based on population surveys in the eastern part of Germany. Eur Psychiatry 2009; 24: 225–232.CrossRefGoogle ScholarPubMed
Barbui, C, Nose, M, Mazzi, MA, Thornicroft, G, Schene, A, Becker, T, et al.Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries. Int Clin Psychopharmacol 2006; 21: 355–362.CrossRefGoogle ScholarPubMed
Bardenstein, KK, McGlashan, THGender differences in affective, schizoaffective, and schizophrenic disorders. A review. Schizophr Res 1990; 3: 159–172.CrossRefGoogle ScholarPubMed
Barnes, M, Lawford, BR, Burton, SC, Heslop, KR, Noble, EP, Hausdorf, K, et al.Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use? Aust N Z J Psychiatry 2006; 40: 575–580.CrossRefGoogle ScholarPubMed
Becker, T, Hulsmann, S, Knudsen, HC, Martiny, K, Amaddeo, F, Herran, A, et al.Provision of services for people with schizophrenia in five European regions. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 465–474.CrossRefGoogle ScholarPubMed
Brieger, P, Wetzig, F, Bocker, FMInstitutions and services of psychiatric care in Saxony-Anhalt: assessment with the European Services Mapping Schedule. Eur Psychiatry 2003; 18: 145–147.CrossRefGoogle ScholarPubMed
De Girolamo, G, Barbato, A, Bracco, R, Gaddini, A, Miglio, R, Morosini, P, et al.Characteristics and activities of acute psychiatric in-patient facilities: national survey in Italy. Br J Psychiatry 2007; 191: 170–177.CrossRefGoogle ScholarPubMed
de Leon, J, Diaz, FJA meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005; 76: 135–157.CrossRefGoogle ScholarPubMed
Dixon, LDual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res 1999; 35 Suppl.: S93–S100.CrossRefGoogle ScholarPubMed
Eaton, WW, Mortensen, PB, Herrman, H, Freeman, H, Bilker, W, Burgess, P, et al.Long-term course of hospitalization for schizophrenia: part I. Risk for rehospitalization. Schizophr Bull 1992; 18: 217–228.CrossRefGoogle ScholarPubMed
Economou, M, Richardson, C, Gramandani, C, Stalikas, A, Stefanis, CKnowledge about schizophrenia and attitudes towards people with schizophrenia in Greece. Int J Soc Psychiatry 2009; 55: 361–371.CrossRefGoogle Scholar
European Commission. Psychiatric care beds in hospitals. 2010, http://epp.eurostat.ec.europa.eu/portal/page/portal/product_details/dataset?p_product_code=TPS00047Google Scholar
Fortney, JC, Xu, S, Dong, FCommunity-level correlates of hospitalizations for persons with schizophrenia. Psychiatr Serv 2009; 60: 772–778.CrossRefGoogle ScholarPubMed
Gerding, LB, Labbate, LA, Measom, MO, Santos, AB, Arana, GWAlcohol dependence and hospitalization in schizophrenia. Schizophr Res 1999; 38: 71–75.CrossRefGoogle Scholar
Gianfrancesco, F, Rajagopalan, K, Wang, RHHospitalization risks in the treatment of schizophrenia: comparison of antipsychotic medications. J Clin Psychopharmacol 2006; 26: 401–404.CrossRefGoogle ScholarPubMed
Gianfrancesco, F, Wang, RH, Pesa, J, Rajagopalan, KHospitalisation risks in the treatment of schizophrenia in a Medicaid population: comparison of antipsychotic medications. Int J Clin Pract 2006; 60: 1419–1424.CrossRefGoogle Scholar
Goff, DC, Henderson, DC, Amico, ECigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am J Psychiatry 1992; 149: 1189–1194.Google ScholarPubMed
Gorwood, P, Leboyer, M, Jay, M, Payan, C, Feingold, JGender and age at onset in schizophrenia: impact of family history. Am J Psychiatry 1995; 152: 208–212.Google ScholarPubMed
Haro, JM, Ciudad, A, Alonso, J, Bousono, M, Suarez, D, Novick, D, et al.Remission and relapse in the outpatient treatment of patients with schizophrenia. Outcomes at 3 years. Actas Esp Psiquiatr 2008; 36: 187–196.Google ScholarPubMed
Hattori, I, Higashi, TSocioeconomic and familial factors in the involuntary hospitalization of patients with schizophrenia. Psychiatry Clin Neurosci 2004; 58: 8–15.CrossRefGoogle ScholarPubMed
Kahn, RS, Fleischhacker, WW, Boter, H, Davidson, M, Vergouwe, Y, Keet, IP, et al.Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 2008; 371: 1085–1097.CrossRefGoogle ScholarPubMed
Kashner, TM, Rader, LE, Rodell, DE, Beck, CM, Rodell, LR, Muller, KFamily characteristics, substance abuse, and hospitalization patterns of patients with schizophrenia. Hosp Community Psychiatry 1991 42 195–196http://epp.eurostat.ec.europa.eu/portal/page/portal/product_details/dataset?p_product_code=TPS00047Google ScholarPubMed
Kozma, CM, Dirani, RG, Canuso, CM, Mao, LPredicting hospital admission and discharge with symptom or function scores in patients with schizophrenia: pooled analysis of a clinical trial extension. Ann Gen Psychiatry 2010;9():24CrossRefGoogle ScholarPubMed
Law, MR, Soumerai, SB, Ross-Degnan, D, Adams, ASA longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J Clin Psychiatry 2008; 69: 47–53.CrossRefGoogle Scholar
Leung, A, Chue, PSex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 2000; 401: 3–38.CrossRefGoogle ScholarPubMed
Lincoln, TM, Arens, E, Berger, C, Rief, WCan antistigma campaigns be improved? A test of the impact of biogenetic vs psychosocial causal explanations on implicit and explicit attitudes to schizophrenia. Schizophr Bull 2008; 34:984–994.CrossRefGoogle Scholar
Madianos, MG, Zacharakis, C, Tsitsa, CUtilization of psychiatric inpatient care in Greece: a nationwide study (1984-1996). Int J Soc Psychiatry 2000; 46: 89–100.CrossRefGoogle ScholarPubMed
Munk-Jorgensen, P, Mortensen, PB, Machon, RAHospitalization patterns in schizophrenia. A 13-year follow-up. Schizophr Res 1991; 4: 1–9.CrossRefGoogle ScholarPubMed
Papageorgiou G, Cañas F, Zink M, Rossi A. Country differences in patient characteristics and treatment in schizophrenia: data from a physician-based survey in Europe. Eur Psychiatry 2011.CrossRefGoogle Scholar
World Health Organisation (2005) Mental Health Atlas. WHO, Geneva.Google Scholar
Submit a response

Comments

No Comments have been published for this article.